The field of epilepsy management has seen significant advancements in recent years. This article aims to provide healthcare professionals with a comprehensive update on these developments, to enhance patient care and outcomes.
New antiepileptic drugs (AEDs) have been introduced, offering improved efficacy and tolerability. These include brivaracetam, perampanel, and eslicarbazepine. Brivaracetam has shown promise in controlling focal seizures, while perampanel is effective for both focal and primary generalized tonic-clonic seizures. Eslicarbazepine offers a once-daily dosing option and fewer side effects.
Neuromodulation techniques such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS) have gained acceptance for drug-resistant epilepsy. VNS involves electrical stimulation of the vagus nerve, RNS monitors brain activity and delivers electrical pulses to prevent seizures, while DBS targets specific brain areas.
Minimally invasive surgical techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided radiofrequency thermocoagulation (SEEG-RFTC), have revolutionized epilepsy surgery. LITT uses laser-induced heat to ablate seizure foci, and SEEG-RFTC employs radiofrequency energy for the same purpose, both minimizing brain tissue damage.
Genomic medicine has improved our understanding of epilepsy's genetic basis, enabling personalized treatment strategies. Next-generation sequencing technologies have identified numerous epilepsy-associated genes, facilitating early diagnosis and targeted therapy.
These advancements in epilepsy management are transforming patient care, improving seizure control, and enhancing quality of life. It is crucial for healthcare professionals to stay updated with these developments to deliver optimal patient care. Further research will undoubtedly usher in more breakthroughs in this field.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation